Parkinson’s Disease Market Share, Trend, Segmentation and Forecast to 2029
The rise in the prevalence of Parkinson's disease among population across the globe acts as one of the major factors driving the growth of Parkinson's disease market. The increase in demand for combination treatments that assist in neural transplantation, prolonged action of unremitting dopaminergic stimulation medicines and gene therapy and initiatives by government bodies through the form of funding accelerate the Parkinson's disease market growth. The increase in number of patient visits to the hospital owing to the availability of diagnostic laboratories and rise in usage of L-Dopa, a symptomatic dopamine replacement treatment along with nigrostriatal system further influences the Parkinson's disease market. Additionally, improving healthcare system, growth in population, research and development activities and rise in healthcare expenditure positively affect the Parkinson's disease market. Furthermore, patent expiry of branded drugs and strong drug pipeline extend profitable opportunities to the Parkinson's disease market players in the forecast period of 2021 to 2028.
Comments
Post a Comment